Silk polymer-based adenosine release: Therapeutic potential for epilepsy

Biomaterials

Volumn 29, Issue 26, 2008, Pages 3609-3616

  Wilz, Andrew ^a   Pritchard, Eleanor M ^b   Li, Tianfu ^a   Lan, Jing Quan ^a   Kaplan, David L ^b   Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

^b Tufts University   (United States)

Author keywords

Adenosine; Brain; Controlled drug release; Drug delivery; Epilepsy; Silk

Indexed keywords

CHEMICALS; COATING TECHNIQUES; COMPUTER NETWORKS; DRUG THERAPY; MERGERS AND ACQUISITIONS; METALLIZING; PHOTORESISTS; SILK;

BRAIN IMPLANTS; CLINICAL APPLICATIONS; DOSE DEPENDENT; DOSE RESPONSE STUDY; ELSEVIER (CO); EPILEPTOGENESIS; HISTOLOGICAL ANALYSIS; IN-VITRO; NANO FILMS; RAT MODELS; SILK PROTEINS; SILK-FIBROIN (SF);

POLYMERS;

ADENOSINE; MICROSPHERE; NANOFILM; POLYMER; SILK FIBROIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRODE; EMBEDDING; EPILEPSY; EPILEPTOGENESIS; HIPPOCAMPUS; HISTOLOGY; IMPLANT; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ADENOSINE; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPILEPSY; FIBROINS; HIPPOCAMPUS; HUMANS; KINDLING, NEUROLOGIC; MALE; MATERIALS TESTING; MICROSPHERES; POLYMERS; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SILK;

ADENOSINE; COATING; COMPUTERS; DISEASES; MERGERS AND ACQUISITIONS; METALIZATION; NETWORKS; POLYMERS; SCAFFOLDS; SILK;

RATTUS;

EID: 46149117721     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.05.010     Document Type: Article

References (52)

1. Vajda F.J.E. Pharmacotherapy of epilepsy: new armamentarium, new issues. J Clin Neurosci 14 9 (2007) 813-823
2. Nilsen K.E., and Cock H.R. Focal treatment for refractory epilepsy: hope for the future?. Brain Res Brain Res Rev 44 2-3 (2004) 141-153
3. Pitkanen A., Kharatishvili I., Karhunen H., Lukasiuk K., Immonen R., Nairismagi J., et al. Epileptogenesis in experimental models. Epilepsia 48 Suppl. 2 (2007) 13-20
4. Kohling R. Pathophysiology of epilepsy. Klin Neurophysiol 37 4 (2006) 216-224
5. Duncan J.S., Sander J.W., Sisodiya S.M., and Walker M.C. Adult epilepsy. Lancet 367 9516 (2006) 1087-1100
6. Loscher W., Gernert M., and Heinemann U. Cell and gene therapies in epilepsy - promising avenues or blind alleys?. Trends Neurosci 31 2 (2008) 62-73
7. Shetty A.K., and Hattiangady B. Concise review: prospects of stem cell therapy for temporal lobe epilepsy. Stem Cells 25 10 (2007) 2396-2407
8. Raedt R., Van Dycke A., Vonck K., and Boon P. Cell therapy in models for temporal lobe epilepsy. Seizure-Eur J Epilep 16 7 (2007) 565-578
9. Noe F., Nissinen J., Pitkanen A., Gobbi M., Sperk G., During M., et al. Gene therapy in epilepsy: the focus on NPY. Peptides 28 2 (2007) 377-383
10. Boison D. Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol 5 2 (2007) 115-125
11. Li T., Ren G., Lusardi T., Wilz A., Lan J.Q., Iwasato T., et al. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest 118 2 (2008) 571-582
12. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol 84 (2008) 249-262
13. Boison D. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener Dis 4 1 (2007) 28-33
14. Li T., Steinbeck J.A., Lusardi T., Koch P., Lan J.Q., Wilz A., et al. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130 5 (2007) 1276-1288
15. Huber A., Padrun V., Deglon N., Aebischer P., Mohler H., and Boison D. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A 98 13 (2001) 7611-7616
16. Boison D., Scheurer L., Tseng J.L., Aebischer P., and Mohler H. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol 160 1 (1999) 164-174
17. 1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol 193 (2005) 53-64
18. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44 7 (2003) 877-885
19. Güttinger M., Fedele D.E., Koch P., Padrun V., Pralong W., Brüstle O., et al. Suppression of kindled seizures by paracrine adenosine release from stem cell derived brain implants. Epilepsia 46 8 (2005) 1-8
20. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 24 3 (2003) 401-416
21. Horan R.L., Antle K., Collette A.L., Wang Y., Huang J., Moreau J.E., et al. In vitro degradation of silk fibroin. Biomaterials 26 17 (2005) 3385-3393
22. Jin H.J., and Kaplan D.L. Mechanism of silk processing in insects and spiders. Nature 424 6952 (2003) 1057-1061
23. Li C., Vepari C., Jin H.J., Kim H.J., and Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27 16 (2006) 3115-3124
24. Dehdashti A.R., Muster M., Reverdin A., de Tribolet N., and Ruefenacht D.A. Preoperative silk suture embolization of cerebral and dural arteriovenous malformations. Neurosurg Focus 11 5 (2001) e6
25. Schmutz F., McAuliffe W., Anderson D.M., Elliott J.P., Eskridge J.M., and Winn H.R. Embolization of cerebral arteriovenous malformations with silk: histopathologic changes and hemorrhagic complications. Am J Neuroradiol 18 7 (1997) 1233-1237
26. Hofmann S., Foo C.T., Rossetti F., Textor M., Vunjak-Novakovic G., Kaplan D.L., et al. Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 111 1-2 (2006) 219-227
27. Wang X., Wenk E., Hu X., Castro G.R., Meinel L., Wang X., et al. Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 28 28 (2007) 4161-4169
28. Wang X., Kim H.J., Xu P., Matsumoto A., and Kaplan D.L. Biomaterial coatings by stepwise deposition of silk fibroin. Langmuir 21 24 (2005) 11335-11341
29. Sofia S., McCarthy M.B., Gronowicz G., and Kaplan D.L. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54 1 (2001) 139-148
30. Karageorgiou V., Meinel L., Hofmann S., Malhotra A., Volloch V., and Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71 3 (2004) 528-537
31. Kim U.J., Park J., Kim H.J., Wada M., and Kaplan D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26 15 (2005) 2775-2785
32. Wojcik W.J., and Neff N.H. Adenosine measurement by a rapid HPLC-fluorometric method: induced changes of adenosine content in regions of rat brain. J Neurochem 39 (1982) 280-282
33. Rosenfeld S.S., and Taylor E.W. Reactions of 1-N6-ethenoadenosine nucleotides with myosin subfragment 1 and acto-subfragment 1 of skeletal and smooth muscle. J Biol Chem 259 19 (1984) 11920-11929
34. Boison D., Huber A., Padrun V., Deglon N., Aebischer P., and Mohler H. Seizure suppression by adenosine-releasing cells is independent of seizure frequency. Epilepsia 43 8 (2002) 788-796
35. Racine R. Kindling: the first decade. Neurosurgery 3 2 (1978) 234-252
36. Wyckhuys T., De Smedt T., Claeys P., Raedt R., Waterschoot L., Vonck K., et al. High frequency deep brain stimulation in the hippocampus modifies seizure characteristics in kindled rats. Epilepsia 48 8 (2007) 1543-1550
37. Sun F.T., Morrell M.J., and Wharen Jr. R.E. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics 5 1 (2008) 68-74
38. Milby A.H., Halpern C.H., and Baltuch G.H. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 5 1 (2008) 75-85
39. Liebetanz D., Klinker F., Hering D., Koch R., Nitsche M.A., Potschka H., et al. Anticonvulsant effects of transcranial direct-current stimulation (tDCS) in the rat cortical ramp model of focal epilepsy. Epilepsia 47 7 (2006) 1216-1224
40. Yang X.F., Kennedy B.R., Lomber S.G., Schmidt R.E., and Rothman S.M. Cooling produces minimal neuropathology in neocortex and hippocampus. Neurobiol Dis 23 3 (2006) 637-643
41. Thompson K.W. Genetically engineered cells with regulatable GABA production can affect afterdischarges and behavioral seizures after transplantation into the dentate gyrus. Neuroscience 133 4 (2005) 1029-1037
42. Carpentino J.E., Hartman N.W., Grabel L.B., and Naegele J.R. Region-specific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures. J Neurosci Res 86 3 (2008) 512-524
43. Vezzani A. The promise of gene therapy for the treatment of epilepsy. Expert Rev Neurother 7 12 (2007 Dec) 1685-1692
44. Foti S., Haberman R.P., Samulski R.J., and McCown T.J. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther 14 21 (2007) 1534-1536
45. McCown T.J. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14 1 (2006) 63-68
46. Raol Y.H., Lund I.V., Bandyopadhyay S., Zhang G., Roberts D.S., Wolfe J.H., et al. Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci 26 44 (2006) 11342-11346
47. Masino SA, Geiger J. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci 2008, May 7 [Epub ahead of print] PMID: 18471903.
48. Stainman R.S., Turner Z., Rubenstein J.E., and Kossoff E.H. Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy. Seizure 16 7 (2007) 615-619
49. Gouder N., Scheurer L., Fritschy J.M., and Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24 3 (2004) 692-701
50. Bekar L., Libionka W., Tian G.F., Xu Q., Torres A., Wang X., et al. Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat Med 14 1 (2008) 75-80
51. Trayer I.P., Trayer H.R., Small D.P., and Bottomley R.C. Preparation of adenosine nucleotide derivatives suitable for affinity chromatography. Biochem J 139 3 (1974) 609-623
52. Ren G., Li T., Lan J.Q., Wilz A., Simon R.P., and Boison D. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208 (2007) 26-37